Characterization of NS3 protease from an Egyptian HCV genotype 4a isolate

Archives of Virology

Volumn 154, Issue 10, 2009, Pages 1649-1657

  Bahgat, Mahmoud Mohamed ^a   Ibrahim, Ahmed Atef ^a   Abd Elshafy, Dina Nadeem ^a   Mesalam, Ahmed Atef ^a   Gewaid, Hossam Eid ^a   Ismaeil, Amany Abd Elghany ^a   El Waseef, Ahmed Mohamed ^b   Maghraby, Amany Sayed ^a   Barakat, Ahmed Barakat ^c   El Far, Mohamed Abd Elhafez ^b   Ghanem, Hossam El Din Ahmed ^c   Mohamed, Amro Mahmoud ^a   Ali, Mohamed Ahmed ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b Mansoura University   (Egypt)

^c Ain Shams University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

NS3 PROTEIN, HEPATITIS C VIRUS; VIRUS PROTEIN;

ANIMAL; ARTICLE; CELL LINE; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MACROPHAGE; MOLECULAR CLONING; MOUSE; PHYLOGENY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; VIROLOGY; VIRUS REPLICATION;

ANIMALS; CELL LINE; CLONING, MOLECULAR; EGYPT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MACROPHAGES; MICE; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); HEPATITIS C VIRUS; MAMMALIA; MUS;

EID: 70350392817     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-009-0500-z     Document Type: Article

References (42)

1. Aach RD, Stevens CE (1991) Hepatitis C virus infection in posttransfusion hepatitis: An analysis with first and second generation assays. N Engl J Med 325:1325-1329.
2. Ahlen G, Nystrom J, Pult I, Frelin L, Hultgren C, Sallberg M (2005) In vivo clearance of hepatitis C virus nonstructural 3/4A-expressing hepatocytes by DNA vaccine-primed cytotoxic T lymphocytes. J Infect Dis 192:2112-2116.
3. Bahgat M, Sorgho H, Ouédraogo JB, Poda JN, Sawadogo L, Ruppel A (2006) Enzyme-linked immunosorbent assay with worm vomit and cercarial secretions of Schistosoma mansoni to detect infections in an endemic focus of Burkina Faso. J Helminthol 80:19-23.
4. Barbato G, Cicero DO, Nardi MC, Steinkuhler C, Cortese R, De Francesco R, Bazzo R (1999) The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism. J Mol Biol 289:371-384.
5. Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H (1993) Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol 67:3835-3844.
6. Bartenschlager R, Lohmann V (2000) Replication of the hepatitis C virus. Baillieres Best Pract Res Clin Gastroenterol 14:241-254.
7. Bazan JF, Fletterick RJ (1989) Detection of a trypsin-like serine protease domain in flaviviruses and pestiviruses. Virology 171:637-639.
8. Bernardin F, Abdel-Hamid M, Cooper S, Wakil E, Nygaard K, Ostrowski MJ, Mohamed MK, Fontanet A, Delwart EL (2006) Direct submission. Blood Systems Research Institute, University of California at San Francisco, 270 Masonic Avenue, San Francisco, CA 94118, USA.
9. Chamberlain RW, Adams N, Saeed AA, Simmonds P, Elliott RM (1997) Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol 78:1341-1347.
10. Chang KM, Thimme R, Melpolder JJ, Oldach D, Pemberton J, Moorhead-Loudis J, McHutchison JG, Alter HJ, Chisari FV (2001) Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology 33:267-276.
11. Chen C, Okayama H (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752.
12. Chevaliez S, Pawlotsky JM (2007) Hepatitis C virus: Virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13:2461-2466.
13. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D, Pape GR (1995) Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006-1007.
14. Encke J, zu Putlitz J, Geissler M, Wands JR (1998) Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model. J Immunol 161:4917-4923.
15. Foy E, Li K, Wang C, Sumpter R Jr, Ikeda M, Lemon SM, Gale M Jr (2003) Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300:1145-1148.
16. Franco S, Tural C, Clotet B, Martinez MA (2007) Complete nucleotide sequence of genotype 4 hepatitis C viruses isolated from patients co-infected with human immunodeficiency virus type 1. Virus Res 123:161-169.
17. Frelin L, Alheim M, Chen A, Soderholm J, Rozell B, Barnfield C, Liljestrom P, Sallberg M (2003) Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo. Gene Ther 10:686-699.
18. Frelin L, Ahlen G, Alheim M, Weiland O, Barnfield C, Liljestrom P, Sallberg M (2004) Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene. Gene Ther 11:522-533.
19. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL Jr, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347:975-982.
20. Fytili P, Dalekos GN, Schlaphoff V, Suneetha PV, Sarrazin C, Zauner W, Zachou K, Berg T, Manns MP, Klade CS, Cornberg M, Wedemeyer H (2008) Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073. Vaccine 26:3818-3826.
21. Gudim EA, Agapov II, Komolov IS, Tonevitskii AG (2005) Humoral immune response to recombinant viral NS3 protein in patients with hepatitis C. Bull Exp Biol Med 139:77-80.
22. Halfon P, Bourlière M, Khiri H, Halimi G, Gerolami V, Feryn JM, Ouzan D (2002) Serological response to infection with different isolates of hepatitis c virus. J Viral Hepat 9:438-442.
23. Kamal SM (2009) Hepatitis C genotype 4 therapy: Increasing options and improving outcomes. Liver Int 1:39-48.
24. Kanistanon D, Wongprompitak P, Dharakul T, Songsivilai S (2002) Hepatitis C virus nonstructural 3 protein: Recombinant NS3 protein of the Thai isolates as an antigen in a diagnostic assay. Asian Pac J Allergy Immunol 20:161-166.
25. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
26. Liu-Young G, Kozal MJ (2008) Hepatitis C protease and polymerase inhibitors in development. AIDS Patient Care STDS 22:449-457.
27. Maniatis T, Fritsch EF, Sambrook J (1982) Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor.
28. Neville JA, Prescott LE, Bhattacherjee V, Adams N, Pike I, Rodgers B, El-Zayadi A, Hamid S, Dusheiko GM, Saeed AA, Haydon GH, Simmonds P (1997) Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus. J Clin Microbiol 35:3062-3070.
29. Parfieniuk A, Jaroszewicz J, Flisiak R (2007) Specifically targeted antiviral therapy for hepatitis C virus. World J Gastroenterol 13:5673-5681.
30. Pearlman BL (2004) Hepatitis C treatment update. Am J Med 117:344-352.
31. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL (2000) Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 182:698-707.
32. Sallberg M, Zhang ZX, Chen M, Jin L, Birkett A, Peterson DL, Milich DR (1996) Immunogenicity and antigenicity of the ATPase/helicase domain of the hepatitis C virus nonstructural 3 protein. J Gen Virol 77:2721-2728.
33. Seipp S, Mueller HM, Pfaff E, Stremmel W, Theilmann L, Goeser T (1997) Establishment of persistent hepatitis C virus infection and replication in vitro. J Gen Virol 78:2467-2476.
34. Soderholm J, Ahlen G, Kaul A, Frelin L, Alheim M, Barnfield C, Liljestrom P, Weiland O, Milich D, Bartenschlager R, Sallberg M (2006) Relation between viral fitness and immune escape within the hepatitis C virus protease. Gut 55:266-274.
35. Soderholm J, Sallberg M (2006) A complete mutational fitness map of the hepatitis C virus nonstructural 3 protease: Relation to recognition by cytotoxic T lymphocytes. J Infect Dis 194:1724-1728.
36. Strickland GT, El-Kamary SS, Klenerman P, Nicosia A (2008) Hepatitis C vaccine: Supply and demand. Lancet Infect Dis 8:379-386.
37. Tanji Y, Hijikata M, Hirowatari Y, Shimotohno K (1994) Identification of the domain required for trans-cleavage activity of the hepatitis C viral serine proteinase. Gene 145:215-219.
38. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV (2001) Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194:1395-1406.
39. Timm J, Neukamm M, Kuntzen T, Kim AY, Chung RT, Brander C, Lauer GM, Walker BD, Allen TM (2007) Characterization of full-length hepatitis C virus genotype 4 sequences. J Viral Hepat 14:330-337.
40. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
41. Uyttendaele S, Claeys H, Mertens W, Verhaert H, Vermylen C (1994) Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Vox Sang 66:122-129.
42. van der Poel CL, Cuypers HT, Reesink HW, Weiner AJ, Quan S, Di Nello R, van Boven JJ, Winkel I, Mulder-Folkerts D, Exel-Oehlers PJ et al (1991) Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 337:317-319.